Editor's Note: In Thursday's MyVU, the headline of the Quantum Potential podcast story was inaccurate and has been corrected below.
#VU2025
Logan Northcutt is driven to fight cancer and support future scientists
Hear from Class of 2025 graduate and cancer biologist Logan Northcutt on his dream to inspire young scientists.Read More
RESEARCH
Winning the War on Bacteria
Crucial research by Neil Osheroff and his lab have lead to approval of the first new class of antibacterial drugs in decades. The drug, gepotidacin, developed by GlaxoSmithKline under the brand name Blujepa, will be available starting later this year, potentially bringing relief to thousands of women who struggle with uncomplicated urinary tract infections. Read More
ATHLETICS
Ashby drafted by Patriots
Vanderbilt cemented its special teams reputation Saturday as long snapper Julian Ashby was chosen by the New England Patriots in the seventh round of the 2025 NFL Draft. Ashby was selected 251st overall and is the first draft pick under Clark Lea to have finished his eligibility at Vanderbilt.Read More
Vanderbilt University students, faculty and staff can create accounts to access select newspapers online. This access is sponsored by the Libraries. Information on how to activate subscriptions isavailable here.
MyVU provides top news and information each week for faculty, staff, and students of Vanderbilt University and is published by Communications and Marketing.
